Trichomonas vaginalis: Difference between revisions

Line 17: Line 17:
==Management==
==Management==
{{Trichomonas antibiotics}}
{{Trichomonas antibiotics}}
==Disposition==
*Outpatient


==See Also==
==See Also==

Revision as of 02:56, 20 August 2016

Background

  • Considered an STI
  • Associated with preterm birth, PID, cervical cancer, increased transmission of other STIs

Clinical Features

  • Yellow, malordorous discharge
  • Vaginal erythema or edema

Differential Diagnosis

Vulvovaginitis

Sexually transmitted diseases

Evaluation

  • Wet mount shows mobile trichomonads

Management

Non-Pregnant

Pregnant

Only treat if the patient is symptomatic and avoid breast feeding until 24-hrs after last dose

Sexual Partner Treatment

Men

Disposition

  • Outpatient

See Also

References

  1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  2. CDC Trichomoniasis 2015. https://www.cdc.gov/std/tg2015/trichomoniasis.htm
  3. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon